3Jin L,Jin H,Zhang G,et al.Changes in coagulation and tissue plasminogen activator after the treatment of cerebral infarction w oth lumbrokinase[J].Clin Hemorhrol M icrocirc,2000,23(224):213-218. 被引量：1
4WHO.Intemational statistical classification of diseases and related health problems[M].10th ed.Geneva:World Health Organization,2010. 被引量：1
5van Hylckama Vieg A,Rosendaal F R.High levels of fibrinogen are associated w ith the rise of deep venous thrombosis mainly in the erderly[J].J Thromb Haemost,2013,1(12):2677-2678. 被引量：1
6Yukizawa Y,Inaba Y,Watanabe S,et al.Association betw een venous thrombembolism and plasma levels of both soluble fibrin and plasminogen-activator inhibitor 1 in 170patients undergoing total hip arthroplasty[J].Aeta Orthop,2012,83(1):14-21. 被引量：1
7Stang L J.D-dimer and fibrinogen/fibrin degradation products[J].M ethods M ol Biol,2013,992:415-427. 被引量：1
8Wong P,Baglin T.Epidemiology,risk factors and sequelae of venous thromboembolism[J].Phlebology,2012,27(2):2-11. 被引量：1
9Barba R,Zapatero A,Losa J E,et al.Venous thromboembolism in acutely ill hospitalized medical patients[J].Thromb Res,2010,126(4):276-279. 被引量：1
10Levy Y D,Hardwick M E,Copp S N,et al.Thrombosis incidence in unilateral vs simultaneous bilateral total knee arthroplasty w ith compression device prophylaxis[J].J Arthroplasty,2012,8(12):570-580. 被引量：1
